Dr. Reddy's Laboratories Limited
SOLID FORMS OF IBRUTINIB
Last updated:
Abstract:
The present invention describes solvates of Ibrutinib and processes for their preparation, pharmaceutical compositions comprising these solvate forms. The present invention also describes co-crystal, obtained from Ibrutinib and a neutral conformer, where both are solids at room temperature, process for their preparation, pharmaceutical compositions comprising the co-crystals and the use of these solids forms for the treatment of Burton's tyrosine kinase (BTK) mediated diseases.
Status:
Application
Type:
Utility
Filling date:
9 Jan 2019
Issue date:
7 Jan 2021